Spain· ES:91389
FIBRYGA 2 G POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE Y PARA PERFUSION
A medicinal product containing fibrinógeno humano, registered in Spain by Octapharma S.A..
Checked against AEMPS CIMA (Spain) on
Informational only — not a medical device.
The record
At a glance
AEMPS CIMA (Spain)- Active substance
- fibrinógeno humano
- Manufacturer
- Octapharma S.A.
- Country
- Spain (ES)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- AEMPS CIMA (Spain)
- Last checked
- July 6, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Fibrinógeno humano in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandFibrygaOctapharma AB
- PolandFibrygaOctapharma (IP) SPRL
- SwedenFibryga 2 g Pulver och vätska till injektions-/infusionsvätska, lösningOctapharma AB
- BelgiumRiastap 2 gCSL Behring
- IrelandFIBRYGA 2 g powder and solvent for solution for injection/infusionOctapharma (IP)
- SwitzerlandHaemocomplettan P
- United KingdomARTISS solution for sealant 10ml pre-filled syringesBaxter Healthcare Ltd
- NetherlandsFibclot 1,5 g, poeder en oplosmiddel voor oplossing voor injectie/infusieLaboratoire Francais Du Fractionnement Et Des Biotechnologies
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Fibclot, Fibryga
- Belgium · Fibclot, Fibryga
- Bulgaria · Fibryga, Хемокомплетан P
- Cyprus · Fibryga, Riastap
- Czechia · Fibryga, Haemocomplettan P
- Germany · Fibclot, Fibryga
- Denmark · Fibclot, Fibryga
- Estonia · Fibryga
- Finland · Fibclot, Fibryga
- France · Clottafact, Fibryga
- United Kingdom (Northern Ireland) · Fibclot, Fibryga
- Greece · Fibclot, Riastap
- Croatia · Fibryga
- Hungary · Fibclot, Fibryga
- Ireland · Fibryga, Riastap
- Iceland · Fibryga, Riastap
- Italy · Fibriclotte, Fibryga
- Lithuania · Fibryga
- Luxembourg · Fibclot, Fibryga
- Latvia · Fibryga
- Malta · Fibryga, Riastap
- Netherlands · Fibclot, Fibryga
- Norway · Fibclot, Fibryga
- Poland · Fibryga, Riastap
- Portugal · Fibryga, Haemocomplettan
- Romania · Fibryga, Haemocomplettan P
- Sweden · Fibclot, Fibryga
- Slovenia · Fibrema, Prufibry
- Slovakia · Fibryga, Riastap
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AEMPS CIMA (Spain). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/9d9d3e32-747e-4b1f-9eeb-a380c56ae92b GET /v1/drugs/9d9d3e32-747e-4b1f-9eeb-a380c56ae92b?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cpresc": "Uso Hospitalario",
"estado": "{\"aut\":1782741483000}",
"nregistro": "91389",
"substance": "fibrinógeno humano"
}See everything about fibrinógeno humano.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.